Although the cholesterol metabolism pathway was significantly downregulated (including APOA2, APOC1, APOH, CETP, and APOA4), the increased levels of PCSK9 and APOB suggested the dysregulation of cholesterol metabolism in severe and critical COVID-19 patients. The gene discussed is APOA4; the disease is COVID-19.